Hanx Biopharmaceuticals (Wuhan) Co. Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board is chaired by Dr. Zhang Faming, who also serves as Chairperson of the Nomination Committee. Other executive directors include Dr. Henry Qixiang Li (Remuneration Committee member), Mr. Liu Min, and Ms. Xiao Jieyu (Nomination Committee member). The non-executive director is Dr. Li Jian. Independent non-executive directors are Dr. Bi Honggang (member of both the Nomination and Remuneration Committees), Mr. Chen Qifeng (Chairperson of the Audit Committee, member of the Nomination Committee), Mr. Wong Sai Hung (member of the Audit Committee, Chairperson of the Remuneration Committee), and Dr. Zhang Qiongguang (member of the Audit, Nomination, and Remuneration Committees). The company reports three board committees: Audit, Nomination, and Remuneration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals (Wuhan) Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260208-12018620), on February 08, 2026, and is solely responsible for the information contained therein.